PMDA drug package insert
エナジーロラタジン鼻炎薬
PMDA OTC drug · 株式会社エナジー · package insert Jan 21, 2022
Key facts
| Brand names | エナジーロラタジン鼻炎薬 |
|---|---|
| Companies | 製造販売元／新日製薬（株）,販売会社／株式会社エナジー |
| Product type | OTC drug |
| OTC risk class | 第２類医薬品 |
| OTC dosage form | 錠剤 |
| OTC effect category | その他のアレルギー用薬 |
| Package insert date | Jan 21, 2022 |
| PMDA document key | 343020_K2201000006 |
| PMDA company code | 343020 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: